MYL3 antibody

Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
MYL3 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab05487
tested applications
ELISA, IHC, WB, IP

Description

Regulatory light chain of myosin. Does not bind calcium.

Documents del producto

Instrucciones
Descargar
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
myosin, light chain 3, alkali; ventricular, skeletal, slow (MYL3)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
WB: 1:500-1:2000; IHC: 1:50-1:500; IP: 1:2000-1:4000
Clonality
polyclonal
Conjugation
Unconjugated
Isotype
IgG
Observed MW
22-27 kDa
Purity
≥95% as determined by SDS-PAGE
Purification
Immunogen affinity purified
Size 1
100µg
Form
liquid
Tested Applications
ELISA, IHC, WB, IP
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt ID
P08590
Gene ID
4634
Alias
Myosin light chain 3,Cardiac myosin light chain 1 (CMLC1),Myosin light chain 1, slow-twitch muscle B/ventricular isoform (MLC1SB),Ventricular myosin alkali light chain,Ventricular myosin light chain 1 (VLCl),Ventricular/slow twitch myosin alkali light chain (MLC-lV/sb),MYL3
Background
Antibody anti-MYL3
Status
RUO
Note
Mol. Weight 22-27 kDa

Descripción

Related Products

FNab05487

MYL3 antibody

Regulatory light chain of myosin. Does not bind calcium.

Ver Producto
FNab09860

MYL3 antibody

MYL3 encodes myosin light chain 3, an alkali light chain also referred to in the literature as both the ventricular isoform and the slow skeletal muscle isoform. Mutations in MYL3 have been identified as a cause of mid-left ventricular chamber type hypertrophic cardiomyopathy.

Ver Producto
abx005108

Myosin Light Chain 3 (MYL3) Antibody

MYL3 Antibody is a Rabbit Polyclonal antibody against MYL3. MYL3 encodes myosin light chain 3, an alkali light chain also referred to in the literature as both the ventricular isoform and the slow skeletal muscle isoform. Mutations in MYL3 have been identified as a cause of mid-left ventricular chamber type hypertrophic cardiomyopathy.

Ver Producto